Caladrius Biosciences, Inc. (NASDAQ: LSTA) reported Q3 EPS of ($0.65), $0.29 better than the analyst estimate of ($0.94).

For earnings history and earnings-related data on Caladrius Biosciences, Inc. (LSTA) click here.